Teclistamab Shows 'Promising' Activity in R/R Multiple Myeloma

Investigational drug teclistamab is 'a promising new, off-the-shelf, T-cell redirecting therapy targeting BCMA for patients with relapsed or refractory MM,' say researchers. Medscape Medical News